OYSTER POINT PHARMA INC (OYST) Stock Analyst Ratings
USA - NASDAQ:OYST - US69242L1061 - Common Stock
11.17 USD
+0.02 (+0.18%)
11.17 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 78% to OYST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 28.05. This target is 151.12% above the current price.
OYST was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about OYST.
In the previous month the buy percentage consensus was at a similar level.
OYST was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-08 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2022-11-08 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-08-11 | Chardan Capital | Initiate | Buy |
| 2022-07-18 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-09 | JP Morgan | Downgrade | Overweight -> Neutral |
OYSTER POINT PHARMA INC / OYST FAQ
What is the average price target for OYSTER POINT PHARMA INC (OYST) stock?
10 analysts have analysed OYST and the average price target is 28.05 USD. This implies a price increase of 151.12% is expected in the next year compared to the current price of 11.17.
How do analysts rate OYSTER POINT PHARMA INC (OYST)?
The consensus rating for OYSTER POINT PHARMA INC (OYST) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.